Allon Therapeutics Inc.
NPCUF
$0.0001
$0.000.00%
OTC PK
| 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | 03/31/2012 | |
|---|---|---|---|---|---|
| Net Income | -13.24M | -14.95M | -11.65M | -12.84M | -12.65M |
| Total Depreciation and Amortization | 369.40K | 497.90K | 515.50K | 520.00K | 527.10K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 4.36M | 4.46M | 513.20K | 479.20K | 330.80K |
| Change in Net Operating Assets | 850.10K | 714.10K | -495.60K | 1.97M | 660.50K |
| Cash from Operations | -7.66M | -9.28M | -11.12M | -9.88M | -11.13M |
| Capital Expenditure | -- | -- | 0.00 | -1.20K | -4.20K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | 0.00 | -1.20K | -4.20K |
| Total Debt Issued | 0.00 | 2.47M | 2.47M | 2.47M | 2.47M |
| Total Debt Repaid | -2.50M | -2.50M | -2.50M | -2.50M | -- |
| Issuance of Common Stock | 9.63M | 10.13M | 14.18M | 14.18M | 4.68M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -576.60K | -580.30K | -29.80K | -35.70K | 546.80K |
| Cash from Financing | 6.49M | 9.45M | 13.95M | 13.94M | 7.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | 0.00 | 0.00 | -- | -- | -- |
| Net Change in Cash | -1.16M | 175.60K | 2.83M | 4.06M | -3.55M |